Panacea starts Sputnik production | India News – Times of India


NEW DELHI: Panacea Biotec and Russia‘s sovereign wealth fund, Russian Direct Funding Fund (RDIF) introduced the beginning of production of the Sputnik V vaccine.
The industrial manufacture shall be beginning in summer time. Underneath a tie-up, RDIF and Panacea have agreed to provide 100 million doses per yr of the vaccine. Efficacy of Sputnik V is 97.6%.

FbTwitterLinkedinEMail

.



Supply hyperlink

Leave a Reply

%d bloggers like this: